BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer
Brian Diskin, Salma Adam, Gustavo Sanchez Soto, Miguel Liria, Berk Aykut, Belen Sundberg, Eric Li, Joshua Leinwand, Ruonan Chen, Mirhee Kim, Ruben D. Salas, Marcelo Ferreira Cassini, Chandan Buttar, Wei Wang, Mohammad Saad Farooq, Sorin A. A. Shadaloey, Gregor Werba, Fnu Amreek, Fan Yang, Carolina Alcantara Hirsch, John Glinski, Angilee Panjwani, Yael Weitzner, Deirdre Jill Cohen, Usman Asghar, George Miller
Topics & Concepts
Immune systemBiologyImmunotherapyImmunologyPancreatic cancerMetastasisCancer researchPrimary tumorBTLAAntigenCancerCD44T cellCellGeneticsPancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersPhagocytosis and Immune Regulation